HHS Funds Phase 2/3 Clinical Trial for Potential Treatment for COVID-19
March 24, 2020
March 24, 2020
WASHINGTON, March 24 -- The U.S. Department of Health and Human Services issued the following news release:
An antibody medicine being evaluated to treat severe cases of coronavirus disease 2019 (COVID-19) will receive additional support from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) under an existing partnership with Regeneron Pharmaceuticals of Tarrytown, New York.
The Biomedical Advanced R . . .
An antibody medicine being evaluated to treat severe cases of coronavirus disease 2019 (COVID-19) will receive additional support from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) under an existing partnership with Regeneron Pharmaceuticals of Tarrytown, New York.
The Biomedical Advanced R . . .